Skip to main content
Caplight Logo









Reneural

Reneural

Private
HatfieldHealthcare & Life Scienceshttps://reneural.tech/

Last Round

Grant

Nov 6, 2024

Total Funding Raised

$1.02M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Reneural is a neurotech company that develops a neurorehabilitation platform using virtual reality designed for stroke survivors.

Sector

Healthcare & Life Sciences

Verticals

AR/VR Experiences, Mental Health, Patient Engagement, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

neurorehabilitationvirtual reality therapystroke rehabilitationVR rehabextended realityXRremote patient monitoringRPMdigital healthneuroplasticitytelemedicinehealth techmental health therapyclinical dashboardpatient engagement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Reneural Comparables

Compare Reneural with similar companies based on industry and business-model similarity.

Reneural comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
eXRt Intelligent Healthcare
92%
Eodyne Systems
84%
Neuro Rehab VR
82%

Reneural Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 6, 2024
Pre SeedNov 6, 2024
GrantNov 1, 2022

Reneural Investors

Notable investors and investment history

Reneural investors
InvestorRounds
Innovate UKGrant, Pre Seed
SFC CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 643% MoM, reaching 572.

  • Apr 15, 2026

    Monthly visitors grew 141% MoM, reaching 2.6K.

Reneural Filings

Explore SEC and related filing metadata, where available.

Reneural filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Reneural's valuation, stock price, and market status.

Is Reneural a public or private company?

Reneural is a private company.

What is the current stock price of Reneural?

Reneural is a private company with no public stock price. No recent secondary market data is available.

How much is Reneural worth (valuation)?

Valuation information for Reneural is not publicly available.

Can I buy Reneural stock?

Reneural shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Reneural's last funding round?

Reneural's most recent funding round was Grant on November 6, 2024.

Who are the main investors in Reneural?

Key investors in Reneural include SFC Capital.

Will Reneural IPO soon?

No public IPO plans have been announced for Reneural.

How can I track Reneural secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Reneural's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHatfield
Employee Range4
Year Founded2022
Last FundingNov 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?